BioMedomics, Inc - Product Pipeline Analysis, update 2014

BioMedomics, Inc - Product Pipeline Analysis, update 2014

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

BioMedomics, Inc - Product Pipeline Analysis, update 2014

Summary

BioMedomics, Inc. (BioMedomics) is a medical diagnostics company. The company conducts research and develops assays and technologies for use in molecular diagnostics. Its diagnostic platform technologies include time-resolved lateral flow immunoassay platform, nanotube based highly sensitive biosensor platform, and novel universal bacterial capture technology. BioMedomics offer tests for sickle cell disease, acetaminophen, H.I.T, and alpha-thalassemia. The company's rapid drug overdose test is used to test drugs of abuse including morphine, cocaine, PCP, methamphetamine and THC. It markets its assays and technologies to corporate strategic partners. BioMedomics is headquartered in Durham, North Carolina, the US.

To Browse a Full Report with Toc: http://www.researchmoz.us/biomedomics-inc-product-pipeline-analysis-2014-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BioMedomics, Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

Reasons...

Similar Essays